Pfizer could be left with up to 70 million surplus courses of Paxlovid by the end of 2022, data firm Airfinity warned, but the drug is still on track to be one of the year’s biggest.
The designation is WHO’s highest alert level and is reserved for “serious, sudden, unusual or unexpected” events that threaten more than one country and may require an immediate, coordinated international response.
Europe’s medicines regulator endorsed expanding the label of Bavarian Nordic’s smallpox vaccine to include protection against monkeypox and the shot will now go to the bloc’s executive for final approval.
Experts suggest a strategy focusing on delivering first doses of monkeypox vaccine will help stretch limited supplies amid a worsening outbreak, but officials at the CDC and FDA insist on a two-shot regimen.
BA.5, an omicron offshoot, is behind a surge of new infections in the U.S. and though hospitalizations are also rising, deaths are relatively subdued compared to earlier waves.
Experts and officials have slammed the Biden Administration’s sluggish response to monkeypox as scarce vaccine appointments fill up within minutes of becoming available in areas like New York and Washington, D.C.